Bookmark and Share

Last Minute: "Tory MPs turn on Boris Johnson after he mocks calls to change style and says criticism ?doesn?t matter? - The Independent" Sat, 25 Jun 2022 16:35:11 GMT    "Charles accepted ?1m cash in suitcase from sheikh - The Times" Sat, 25 Jun 2022 17:00:00 GMT    "Horror as man is stabbed to death in Hounslow town centre - Evening Standard" Sat, 25 Jun 2022 12:30:39 GMT    "Rail strikes: RMT union 'won't hesitate' to take further industrial action as third walkout causes weekend disruption - Sky News" Sat, 25 Jun 2022 11:03:45 GMT    "School friends carry coffin of 13-year-old killed in River Taff tragedy as he is laid to rest - Wales Online" Sat, 25 Jun 2022 12:17:40 GMT    "Greta Thunberg delivers a climate warning at Glastonbury - BBC" Sat, 25 Jun 2022 16:52:55 GMT    "Striking RMT union?s Mick Lynch tells Grant Shapps to ?get on with his job? - The Guardian" Sat, 25 Jun 2022 14:04:00 GMT    "Russia pushes to block off city of Lysychansk, says Ukraine - The Guardian" Sat, 25 Jun 2022 16:14:00 GMT    "Vladimir Putin ally warns London ?will be bombed first? if World War 3 breaks out - The Independent" Sat, 25 Jun 2022 16:44:56 GMT    "Abortion ruling shows growing might of US Supreme Court's conservatives - Financial Times" Sat, 25 Jun 2022 09:00:34 GMT      For more news, click here.

Remember me? 

Show More News:
 Watch more news

News search related to the stock Bristol-Myers Squ (ordered by date):

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

  1. Is There More Room For Growth In Bristol Myers Squibb Stock?  Forbes
  2. Why Bristol-Myers Squibb (BMY) Is Buying Turning Point Therapeutics (TPTX) In A $4.1 Billion Deal  Pulse 2.0
  3. Kirkland Represents Bristol Myers Squibb on $4.1 Billion Acquisition of Turning Point Therapeutics | News  Kirkland & Ellis LLP
  4. Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company  Business Wire
  5. Bristol-Myers Squibb (BMY) to Acquire Turning Point Therapeutics (TPTX) for $76 Per Share
Bristol-Myers Squibb (BMY) Stock Price: $80 Target And Buy Rating  Pulse 2.0 Bristol Myers Squibb (BMY): Safe Spot For Worrisome Investor  Seeking Alpha Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference  Yahoo Finance Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at Bernstein 38th Annual Strategic Decisions Conference (Transcript)  Seeking Alpha Should Bristol-Myers Squibb Co (BMY) Stock Be in Your Portfolio?  InvestorsObserver Is Bristol-Myers Squibb Company's (NYSE:BMY) 20% ROE Strong Compared To Its Industry?  Simply Wall St Bristol-Myers, Novartis win FDA label expansions for cancer medications (NYSE:BMY)  Seeking Alpha Bristol Myers' (BMY) Breyanzi sBLA Receives EMA Validation  Zacks Investment Research August 19th Options Now Available For Bristol Myers Squibb (BMY)  Nasdaq 2022-06-24 | NYSE:BMY | Press Release | Bristol-Myers Squibb Company  Stockhouse Bristol-Myers MS drug linked to better COVID response with mRNA shots (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors  Business Wire Bristol Myers Squibb Announces Dividend  Business Wire Bristol-Myers Squibb (NYSE:BMY) Lowered to ?Market Perform? at Raymond James  Defense World Bristol-Myers Squibb hits 52-week high; shares up 27% YTD (NYSE:BMY)  Seeking Alpha UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?  FierceBiotech BMY stock lower after topline results for arthritis drug in COVID-19 (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb a Top Socially Responsible Dividend Stock With 2.9% Yield (BMY)  Nasdaq Biotech Stock Roundup: BMY's Acquisition, REGN to Buy Libtayo & More  Yahoo Finance Bristol-Myers Squibb (NYSE:BMY) Receives Average Recommendation of "Buy" from Brokerages  MarketBeat $11.52 Billion in Sales Expected for Bristol-Myers Squibb (NYSE:BMY) This Quarter  MarketBeat Bristol-Myers Squibb withdraws sBLA for Reblozyl in non-transfusion beta thalassemia  Seeking Alpha Bristol-Myers Squibb (NYSE:BMY) Expected to Announce Quarterly Sales of $11.52 Billion  Defense World Bristol Myers' deucravacitinib improves disease activity in lupus patients in trial  Seeking Alpha Bristol severs Russian ties as Novartis resurrects Ukraine business following safety review  FiercePharma The Zacks Analyst Blog Highlights Tesla, Procter & Gamble, Bristol-Myers Squibb, Wells Fargo and Intuit  Yahoo Finance These Three Drug Stocks Hit New Highs Friday  Investor's Business Daily Hot Stocks: Cruise stocks jump; CAMP plunges on earnings; BMY, LLY set 52-week highs  Seeking Alpha What?s Happening With Bristol Myers Squibb Stock?  Forbes Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript  The Motley Fool UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up  Investor's Business Daily 3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist  Nasdaq Bristol Myers Opdivo/Yervoy combo shows survival benefit in lung cancer in 3-year data  Seeking Alpha Bristol Myers Squibb: A Safe Haven In Times Of Uncertainty  Seeking Alpha Bristol Myers Squibb: Fading The Rally Before Earnings (BMY)  Seeking Alpha Bristol-Myers Squibb Co (BMY) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript)  Seeking Alpha The Days of Big Pharma Are Over. Big Biotech Is on Its Way.  Barron's Bristol-Myers Squibb (BMY) Stock: Quarterly Dividend Declared  Pulse 2.0 'Major blunder': Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update  FiercePharma Bristol-Myers Squibb (BMY) Sells Manufacturing Facility in East Syracuse, New York to LOTTE Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers  Business Wire Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Forbes Bristol-Myers Squibb Snags Another Approval for This Mega-Blockbuster Drug  The Motley Fool Bristol Myers Squibb My Choice For Dividend Growth (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan  FiercePharma Do Options Traders Know Something About Bristol-Myers (BMY) Stock We Don't?  Nasdaq BBIO stock climbs after agreement with Bristol Myers Squibb (NYSE:BMY)  Seeking Alpha Bristol Myers (BMY) Gets EC Nod for Opdivo's Label Expansion  Nasdaq Bristol Myers posts long-term data for heart-disease drug in late-stage trial (NYSE:BMY)  Seeking Alpha Kirkland Represents Bristol-Myers Squibb Company on Offering of $6B of Senior Notes | News  Kirkland & Ellis LLP Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?  The Motley Fool Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference  Yahoo Finance Eli Lilly: Unstoppable Stock Price Progress Can't Last Forever (NYSE:LLY)  Seeking Alpha Bristol Myers Squibb to Participate in Bernstein?s 38th Annual Strategic Decisions Conference  Yahoo Finance Bristol gains approval of first-in-class immunotherapy for melanoma Opdualag (BMY)  Seeking Alpha Thinking about trading options or stock in Block, Lennar, Altria Group, Advanced Micro Devices, or Bristol-Myers Squibb? Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline  Bloomberg Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb  Evotec Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials  Forbes Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies  Yahoo Finance U.S. FTC okays changes to Bristol Meyers Squibb divestiture agreement  Reuters Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities  Business Wire Citigroup Reaffirms Buy Rating for Bristol-Myers Squibb (NYSE:BMY)  Defense World Momelotinib momentum makes GSK's gain Gilead's loss  The Pharma Letter Bristol's Ulcerative Colitis Trial Disappoints. The Stock Is Falling.  Barron's Dow Jones Futures: New Market Rally Struggles For Direction; 5 Stocks Near Buy Points  Investor's Business Daily Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022  Business Wire Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targeted protein degradation approach  Evotec FDA approves expanded use of Bristol Myers cancer drug Opdivo Bristol Myers Squibb to Demonstrate the Strength of its Growing Cardiovascular Portfolio at the American College of Cardiology?s 71st Annual Scientific Session  Yahoo Finance Dow Jones Rises, Techs Lead As Fed Chief Powell Minimizes Recession Risks  Investor's Business Daily 'We Take Care of Our BMS Family' - Bristol Myers Squibb Cancer Support Network  Yahoo Finance Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership  Yahoo Finance Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data  FierceBiotech Bristol-Myers Squibb Company (BMY) Company Profile, News, Rankings | Fortune  Fortune Nektar And Bristol Myers Squibb Expecting Bempeg Approval (NYSE:BMY)  Seeking Alpha Bristol Myers' (BMY) Opdivo Data Positive for Neoadjuvant NSCLC  Nasdaq Bristol Myers Squibb (BMY) Stock: Why The Price Increased Today  Pulse 2.0 Bristol Myers Squibb Presents Interim Results from Long-Term Study Reinforcing Maintenance of Response and Safety Profile of Zeposia (ozanimod) in Patients with Moderately to Severely Active Ulcerative Colitis  Yahoo Finance Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time)  Business Wire Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B  Yahoo Finance Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma  Yahoo Finance FDA approves Bristol Myers' oral heart disease drug Bristol Myers Squibb Co. stock rises Wednesday, still underperforms market  MarketWatch Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts  FiercePharma Bristol Myers sues AstraZeneca over cancer-treatment patents Bristol-Myers Is Said to Have Weighed Offer for Acceleron  Bloomberg Barclays Raises Bristol-Myers Squibb (NYSE:BMY) Price Target to $68.00  Defense World Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics' TCR Bispecific Program IMA401  Business Wire Nektar, Bristol Myers Squibb end clinical development of combination therapy including Opdivo  MarketWatch Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)  Yahoo Finance Should You Buy Bristol Myers Squibb Stock At $63?  Forbes Bristol Myers Squibb's Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency  Business Wire U.S. FDA extends review of Bristol Myers' heart disease drug BMY: 3 Wide-Moat Stocks That Look Cheap: Biogen, Medtronic, and Bristol-Myers Squibb Bristol Myers scores FDA priority review in high-stakes expansion bid for CAR-T drug Breyanzi  FiercePharma Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers  FiercePharma Hennessy Cornerstone Value (HFCVX)'s Data-Driven Success  Nasdaq
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources